These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2879304)

  • 21. Biochemical and behavioral studies of D1 dopamine receptors utilizing SCH 23390.
    Hess EJ; Creese I
    Adv Exp Med Biol; 1986; 204():29-52. PubMed ID: 2878579
    [No Abstract]   [Full Text] [Related]  

  • 22. The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 interactions by muscarinic receptors.
    Wang JQ; McGinty JF
    J Pharmacol Exp Ther; 1997 May; 281(2):972-82. PubMed ID: 9152408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and dopamine receptors binding affinity of 2-(3-fluoro-4-hydroxyphenyl)ethylamine and its N-alkyl derivatives.
    Cardellini M; Cingolani GM; Claudi F; Perlini V; Balduini W; Cattabeni F
    Farmaco Sci; 1988 Jan; 43(1):49-59. PubMed ID: 2899520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute neurobehavioral effects of toluene: involvement of dopamine and NMDA receptors.
    Lo PS; Wu CY; Sue HZ; Chen HH
    Toxicology; 2009 Nov; 265(1-2):34-40. PubMed ID: 19765629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine.
    Duncan GE; Criswell HE; McCown TJ; Paul IA; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1027-34. PubMed ID: 3121842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390.
    Creese I; Chen A
    Eur J Pharmacol; 1985 Feb; 109(1):127-8. PubMed ID: 2859993
    [No Abstract]   [Full Text] [Related]  

  • 28. Enantiomeric analogues of SCH 23390 as new probes for behavioral interactions between D1 and D2 dopaminergic function.
    Waddington JL; Molloy AG; O'Boyle KM; Mashurano M
    Adv Exp Med Biol; 1986; 204():125-36. PubMed ID: 2947424
    [No Abstract]   [Full Text] [Related]  

  • 29. Neuroanatomical, neuropharmacological and neurobiochemical target systems for antipsychotic activity of neuroleptics.
    Delini-Stula A
    Pharmacopsychiatry; 1986 Jul; 19(4):134-9. PubMed ID: 2876445
    [No Abstract]   [Full Text] [Related]  

  • 30. SCH 23390 - the first selective dopamine D-1 antagonist.
    Hyttel J
    Eur J Pharmacol; 1983 Jul; 91(1):153-4. PubMed ID: 6225651
    [No Abstract]   [Full Text] [Related]  

  • 31. Blockade of D-1 dopamine receptors by SCH 23390 prevents EEG and behavioral activation induced by L-dopa.
    Ongini E; Caporali MG; Longo VG
    Neurosci Lett; 1987 Nov; 82(2):206-10. PubMed ID: 2962017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 6-(Phenylthio)-substituted 2,3,4,5-tetrahydro-1H-3-benzazepines, a novel class of dopamine receptor antagonists and neuroleptics.
    Kaiser C; Ali FE; Bondinell WE; Brenner M; Holden KG; Ku TW; Oh HJ; Ross ST; Yim NC; Zirkle CL; Hahn RA; Sarau HM; Setler PE; Wardell JR
    J Med Chem; 1980 Sep; 23(9):975-6. PubMed ID: 6106062
    [No Abstract]   [Full Text] [Related]  

  • 33. Conditioning of signs of a dopaminergic stimulation in rats.
    Kuschinksy K; Möller HG; Novak K; Walter S
    Pharmacopsychiatry; 1988 Nov; 21(6):317-8. PubMed ID: 2907637
    [No Abstract]   [Full Text] [Related]  

  • 34. Neuroleptic CNS effects: acute and chronic studies.
    Bunney BS
    Psychopharmacol Bull; 1979 Jan; 15(1):57-8. PubMed ID: 33410
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of prolactin responses to D-1 and D-2 antagonists in rats: Ro 22-1319 is a potent D-2 antagonist.
    Kaneda H; Shintani T; Kakigi T; Terada T; Tanimoto K
    Biol Psychiatry; 1989 Feb; 25(4):517-22. PubMed ID: 2564788
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dopaminergic receptors, multiple targets for neuroleptics].
    Martres MP; Sokoloff P; Giros B; Bouthenet ML; Pilon C; Lannfelt L; Schwartz JC
    Ann Med Psychol (Paris); 1992; 150(2-3):119-23. PubMed ID: 1364189
    [No Abstract]   [Full Text] [Related]  

  • 37. Peripheral dopamine receptor blockade by SCH 23390 and domperidone in vitro.
    Hilditch A; Drew GM
    Eur J Pharmacol; 1985 Oct; 116(1-2):171-4. PubMed ID: 2865160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The window of vulnerability in the ontogeny of the dopamine receptor.
    Miller JC; Friedhoff AJ
    Psychopharmacol Bull; 1985; 21(3):683-5. PubMed ID: 2863851
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacological and biochemical properties of iminodibenzyl antipsychotic drugs including Y-516 and clocapramine.
    Mikuni M; Yamashita I; Matsubara S; Odagaki Y; Setoguchi M; Fukuda T
    Clin Neuropharmacol; 1986; 9 Suppl 4():319-21. PubMed ID: 2882844
    [No Abstract]   [Full Text] [Related]  

  • 40. Absolute configuration of potentially neuroleptic rigid spiro amines. A study on the topography of the neuroleptic receptor.
    Carnmalm B; Johansson L; Rämsby S; Stjernström NE; Wägner A
    Acta Pharm Suec; 1979; 16(4):239-46. PubMed ID: 44421
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.